See the DrugPatentWatch profile for cosentyx

Are There Risks Using Live Vaccines While on Cosentyx?

Understanding Cosentyx and Live Vaccines

Cosentyx, also known as secukinumab, is a biologic medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It's a powerful tool in the fight against these chronic autoimmune diseases, but like any medication, it's not without its potential risks and interactions.

One important consideration for patients taking Cosentyx is the use of live vaccines. Live vaccines, such as the MMR (measles, mumps, and rubella) vaccine, are designed to introduce a weakened form of the virus or bacteria to the body, allowing the immune system to develop immunity without causing illness. But can patients taking Cosentyx safely receive live vaccines?

The Concerns

The manufacturer of Cosentyx, Novartis, recommends that patients not receive live vaccines while taking the medication. This is because Cosentyx is a biologic medication that suppresses the immune system, which can increase the risk of serious infections.

Live Vaccines and Immune Suppression

When the immune system is suppressed, it's more difficult for the body to mount an effective response to live vaccines. This can lead to a reduced or absent immune response, leaving the patient vulnerable to infection.

The Risks

While the risks associated with using live vaccines while on Cosentyx are generally considered to be low, they are still present. Some of the potential risks include:

* Infection: The most significant risk is the development of serious infections, including opportunistic infections, which can be life-threatening.
* Vaccine Failure: The vaccine may not provide adequate protection against the targeted disease, leaving the patient vulnerable to infection.
* Serious Adverse Reactions: Patients taking Cosentyx may be more susceptible to serious adverse reactions, such as anaphylaxis, to the vaccine.

When Can Patients Receive Live Vaccines?

While patients taking Cosentyx should avoid live vaccines, there are certain circumstances under which it may be safe to receive them. These include:

* After Stopping Treatment: Patients who have stopped taking Cosentyx for at least 12 weeks may be able to receive live vaccines.
* In Special Circumstances: Patients who require a live vaccine for a specific medical condition, such as a travel vaccine, may be able to receive it under the guidance of their healthcare provider.

What Can Patients Do?

If you're taking Cosentyx and need to receive a live vaccine, it's essential to discuss your options with your healthcare provider. They can help you weigh the risks and benefits of receiving the vaccine and develop a plan that's right for you.

Conclusion

While there are risks associated with using live vaccines while on Cosentyx, it's not a blanket prohibition. Patients who need to receive live vaccines should discuss their options with their healthcare provider and weigh the potential risks and benefits.

FAQs

1. Can I receive live vaccines while taking Cosentyx?
* No, patients taking Cosentyx should avoid live vaccines due to the risk of serious infections and vaccine failure.
2. What are the risks associated with using live vaccines while on Cosentyx?
* The risks include infection, vaccine failure, and serious adverse reactions.
3. Can I receive live vaccines after stopping treatment with Cosentyx?
* Yes, patients who have stopped taking Cosentyx for at least 12 weeks may be able to receive live vaccines.
4. Are there any circumstances under which it's safe to receive live vaccines while on Cosentyx?
* Yes, patients who require a live vaccine for a specific medical condition, such as a travel vaccine, may be able to receive it under the guidance of their healthcare provider.
5. What should I do if I need to receive a live vaccine while taking Cosentyx?
* Discuss your options with your healthcare provider and weigh the potential risks and benefits of receiving the vaccine.

Sources

1. Novartis. (2020). Cosentyx Prescribing Information.
2. DrugPatentWatch.com. (2020). Secukinumab (Cosentyx) Patent Expiration.
3. Centers for Disease Control and Prevention. (2020). Live, Attenuated, and Inactivated Vaccines.
4. American Academy of Dermatology. (2020). Psoriasis Treatment Options.
5. National Psoriasis Foundation. (2020). Psoriatic Arthritis Treatment Options.